Sjef van der Linden

15.4k citations

66 papers · 11.8k indexed · 4 hit papers · h-index 35

Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments 30
- Rheumatoid Arthritis Research and Therapies 27
- Systemic Lupus Erythematosus Research 8
Hematology top 0.2%
Immunology top 0.5%
- Psoriasis: Treatment and Pathogenesis 11
Complementary and Manual Therapy top 0.2%
Orthopedics and Sports Medicine top 0.5%
Psychiatry and Mental health
- Fibromyalgia and Chronic Fatigue Syndrome Research 11
Nephrology
- Gout, Hyperuricemia, Uric Acid 8
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 5
Pharmacology
- Musculoskeletal pain and rehabilitation 4

Co-authors: A. Cats Hans A. Valkenburg Désirée van der Heijde Ben A. C. Dijkmans Maarten Boers Robert Landewé Annelies Boonen Ernst Feldtkeller
Cited by: Rheumatology Hematology Immunology
Journals: The Lancet (1 paper)Spine (1 paper)Journal of Clinical Epidemiology (1 paper)
Partner nations: Netherlands Belgium United States

In The Last Decade

Sjef van der Linden

66 papers receiving 11.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Rheumatology International
1997 The Lancet
1991 Arthritis & Rheumatism
1984 Arthritis & Rheumatism

Peers

Countries citing papers authored by Sjef van der Linden

Since Specialization

Citations

This map shows the geographic impact of Sjef van der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sjef van der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sjef van der Linden more than expected).

Fields of papers citing papers by Sjef van der Linden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sjef van der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sjef van der Linden. The network helps show where Sjef van der Linden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sjef van der Linden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sjef van der Linden Line = papers co-authored together Sjef van der Linden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost of Illness and Determinants of Costs Among Patients with Gout The Journal of Rheumatology ·Bart Spaetgens,José M.A. Wijnands,Caroline van Durme,Sjef van der Linden,Annelies Boonen	2014	16
2	The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study Lara D. Veeken ·José M.A. Wijnands,Annelies Boonen,Pieter C. Dagnelie,Marleen M. J. van Greevenbroek,Carla Kallen,Isabel Ferreira,Casper G. Schalkwijk,Edith J. M. Feskens,Coen D.A. Stehouwer,Sjef van der Linden,Ilja C.W. Arts	2014	22
3	Physical Functioning in Patients With Ankylosing Spondylitis JCR Journal of Clinical Rheumatology ·Simon van Genderen,Carlie van den Borne,Piet Geusens,Sjef van der Linden,Annelies Boonen,Guy Plasqui	2014	14
4	Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis The Journal of Rheumatology ·Ben A. C. Dijkmans,Paul Emery,Markku Hakala,Marjatta Leirisalo‐Repo,Emilio Martín Mola,L Paolozzi,Carlo Salvarani,Raimón Sanmartí,Jean Sibilia,Joachim Sieper,Filip Van den Bosch,Désirée van der Heijde,Sjef van der Linden,Joseph Wajdula	2009	51
5	How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured? Arthritis & Rheumatism ·Désirée van der Heijde,Robert Landewé,Sjef van der Linden	2005	28
6	The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis Arthritis & Rheumatism ·Paco M J Welsing,Robert Landewé,Piet L. C. M. van Riel,Maarten Boers,Anke M. van Gestel,Sjef van der Linden,Hilde Swinkels,Désirée van der Heijde	2004	206
7	Markers for type II collagen breakdown predict the effect of disease‐modifying treatment on long‐term radiographic progression in patients with rheumatoid arthritis Arthritis & Rheumatism ·Robert Landewé,Piet Geusens,Maarten Boers,Désirée van der Heijde,Willem F. Lems,Johan te Koppele,Sjef van der Linden,Patrick Garnero	2004	78
8	COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention Arthritis & Rheumatism ·Robert Landewé,Maarten Boers,Arco C. Verhoeven,René Westhovens,Mart A F J van de Laar,H. M. Markusse,J. Christiaan van Denderen,Marie Louise Westedt,André J. Peeters,Ben A. C. Dijkmans,Piet Jacobs,Annelies Boonen,Désirée van der Heijde,Sjef van der Linden	2002	442
9	Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example Arthritis Care & Research ·Karin Bruynesteyn,Désirée van der Heijde,Maarten Boers,Arco C. Verhoeven,Annelies Boonen,Sjef van der Linden,(unknown)	2002	9
10	Reproducibility of clinical performance assessment in practice using incognito standardized patients Medical Education ·Simone Gorter,Jan‐Joost Rethans,Désirée van der Heijde,Albert Scherpbier,Harry Houben,Cees van der Vleuten,Sjef van der Linden	2002	25
11	Seronegative spondyloarthritides Best Practice & Research Clinical Rheumatology ·Ignazio Olivieri,Astrid van Tubergen,Carlo Salvarani,Sjef van der Linden	2002	48
12	Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference Arthritis & Rheumatism ·Karin Bruynesteyn,Désirée van der Heijde,Maarten Boers,Ariane Saudan,Paul M. Peloso,Harold E. Paulus,Harry Houben,Bridget Griffiths,John Edmonds,Barry Bresnihan,Annelies Boonen,Sjef van der Linden	2002	123
13	Assessment of Functional Ability in Younger and Older Patients with Ankylosing Spondylitis American Journal of Physical Medicine & Rehabilitation ·A. Falkenbach,Annegret Franke,Astrid van Tubergen,Sjef van der Linden	2002	10
14	Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis Arthritis & Rheumatism ·Maarten Boers,Piet J. Kostense,Arco C. Verhoeven,Sjef van der Linden,(unknown)	2001	62
15	Combined spa–exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial Arthritis & Rheumatism ·Astrid van Tubergen,R. Landewé,Désirée van der Heijde,Alita Hidding,Nico Wolter,Max Asscher,A. Falkenbach,E. Genth,Henk Goei Thè,Sjef van der Linden	2001	217
16	Spondylarthropathies: options for combination therapy Springer Seminars in Immunopathology ·Astrid van Tubergen,Robert Landewé,Sjef van der Linden	2001	4
17	Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis Current Opinion in Rheumatology ·Sjef van der Linden,Désirée van der Heijde	2000	27
18	Ankylosing spondylitis and other B27 related spondylarthropathies Baillière s Clinical Rheumatology ·Sjef van der Linden,Désirée van der Heijde	1995	6
19	The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathybreakdown → Arthritis & Rheumatism ·Maxime Dougados,Sjef van der Linden,Roger Juhlin,Bernhard Huitfeldt,B Amor,Andrei Călin,A. Cats,Ben A. C. Dijkmans,Ignazio Olivieri,G Pasero,Eric Veys,H. Zeidler	1991	1687
20	Evaluation of Diagnostic Criteria for Ankylosing Spondylitisbreakdown → Arthritis & Rheumatism ·Sjef van der Linden,Hans A. Valkenburg,A. Cats	1984	4427

About Sjef van der Linden

Sjef van der Linden is a scholar working on Rheumatology, Family Practice and Complementary and Manual Therapy, having authored 66 papers that have together received 11.8k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (30 papers), Rheumatoid Arthritis Research and Therapies (27 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (11 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Systemic Lupus Erythematosus Research (8 papers), Gout, Hyperuricemia, Uric Acid (8 papers), Lymphoma Diagnosis and Treatment (5 papers) and Musculoskeletal pain and rehabilitation (4 papers). The work is most often cited by research in Rheumatology (9.9k citations), Hematology (2.9k citations) and Immunology (3.7k citations). Sjef van der Linden has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include A. Cats, Hans A. Valkenburg, Désirée van der Heijde, Ben A. C. Dijkmans, Maarten Boers, Robert Landewé, Annelies Boonen, Ernst Feldtkeller, Ignazio Olivieri and H. Zeidler. Their work appears in journals such as The Lancet, Spine and Journal of Clinical Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact